Skip to main content
. 2017 Apr 25;8(28):45807–45824. doi: 10.18632/oncotarget.17416

Table 8. Univariate and multivariate analyses of clinicopathological variables associated with EGFR-sensitive mutations.

Variable Hazard ratioa 95.0% CI p-value
Univariate analysis
 Age −0.25 −4.05-3.13 0.811
 Sex (male vs. female) 1.60 N/A 0.236
 Complications (no vs. yes) 0.67 N/A 0.478
 Smoker (no vs. yes) 10.58 N/A 0.002*
 miR-107 2.15 0.49–11.34 0.033*
 miR-122 1.58 −0.60–5.40 0.116
 miR-195 −2.36 −7.41–-0.66 0.019*
Multivariate analysis
 Age 2.03 0.93–1.01 0.154
 Sex (male vs. female) 1.08 0.63–4.62 0.299
 Complications (no vs. yes) 2.55 0.86–4.53 0.110
 Smoker (no vs. yes) 9.44 1.85–16.25 0.002*
 miR-107 4.08 0.78–1.00 0.043*
 miR-122 0.69 0.79–1.10 0.405
 miR-195 2.81 0.99–1.07 0.094
Further multivariate analysis
 Smoker (no vs. yes) 9.90 1.55–6.67 0.002*
 miR-107 5.56 0.78–0.98 0.018*

* p < 0.05

aChi-square values for categorical variables and t-test values for continuous variables in the univariate analysis and Wald values for variables in the multivariate analysis

Abbreviations: N/A, not applicable